An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease. (2017)
Attributed to:
Proposal to enhance linked research in human fat metabolism & pathophysiology between MRC HNR, MRC MDU and MRC EU
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.13794
Publication URI: https://www.repository.cam.ac.uk/handle/1810/276408
Type: Journal Article/Review